Skip to main navigation Skip to search Skip to main content

Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future

  • Ahmed Hassanein
  • , Saghir Akhtar*
  • *Corresponding author for this work
  • Qatar University

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Type 1 diabetes mellitus (T1DM) is a serious, chronic metabolic and autoimmune disease that affects millions globally. While insulin administration remains the most effective treatment, it is not a cure. Long-term therapies, such as immunotherapy, can be effective for some patients, but they have notable limitations and do not provide a permanent solution. As a result, current research has shifted towards stem cell-based therapies, which offer a potentially expandable and scalable source of pancreatic beta cells. These therapies aim to restore long-term endogenous β-cell function in all T1DM patients, provided they can avoid immune recognition and rejection by the host. In this review, we will discuss the latest first-in-human successes of stem cell therapies for T1DM. We will then explore stem cell-derived islet encapsulation technologies and hypoimmune stem cells, examining how they might overcome the need for immunosuppressive therapy. Additionally, we will provide a summary of recent and ongoing biopharmaceutical industry pipelines and clinical trials for stem cell therapies aimed at treating T1DM. These advances suggest that stem cell therapies offer a promising and highly effective approach to treating patients with this chronic disease. However, large-scale clinical trials over the long term are necessary to verify these early successes and assess the curative potential of stem cell therapy for T1DM.

Original languageEnglish
Pages (from-to)5-23
Number of pages19
JournalBiomolecules and Biomedicine
Volume26
Issue number1
DOIs
StatePublished - 25 Sep 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • T1DM
  • Type 1 diabetes mellitus
  • encapsulation
  • immunosuppression
  • pancreatic beta cells
  • stem cells

Fingerprint

Dive into the research topics of 'Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future'. Together they form a unique fingerprint.

Cite this